• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鳖甲煎丸联合骨髓间充质干细胞调节 microRNA-140 以抑制肝癌干细胞

Bie Jia Jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells.

作者信息

Jingjing Huang, Hongna Huang, Wenfu Zhang, Jianlin Lv, Guochu Huang, Yuanjia Lin, Songlin Chen, Yueqiang Hu

机构信息

Department of Spleen, Stomach and Liver Diseases, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China.

Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Nanning, China.

出版信息

Int J Stem Cells. 2021 Aug 30;14(3):275-285. doi: 10.15283/ijsc20157.

DOI:10.15283/ijsc20157
PMID:33632990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8429943/
Abstract

BACKGROUND AND OBJECTIVES

Cancer stem cells (CSCs) with tumorigenic potential are reported as the crucial factors of hepatocellular carcinoma (HCC) recurrence and therapy resistance. Bone mesenchymal stem cells (BMSCs) are documented to play an important role in the protection of hepatocytes. Bie Jia Jian pill (BJJP), a Traditional Chinese Medicine, has been used to treat liver fibrosis and liver cancer. This study aimed to explore the potential role of combined use of BJJP with BMSCs in HCC cell lines.

METHODS AND RESULTS

Flow cytometry was used to identify BMSCs isolated from BALB/c mice and CSCs enriched from Huh7 cells by measuring CD24, CD133, CD44, CD73, CD105, CD166, CD29, CD14 and CD34. Differentiation potential of BMSCs was also determined. Cell viability and proliferation ability of CSCs were determined by CCK-8 assay and clone formation assay. The expressions of CSCs biomarkers and Wnt/-catenin signal pathway related proteins were determined by PCR and western blot. TOP-Flash/FOP-Flash luciferase assay was applied to measure the activity of -catenin/TCF. Compared with untreated CSCs, BJJP or BMSCs treatment alone on CSCs lead to increased miR-140 expression and cell apoptosis, as well as decreased expressions of CD24, CD133, EpCAM and cell viability. Downregualted expressions of Wnt/-catenin signal pathway related proteins, Wnt3a and -catenin were found in response to BJJP or BMSCs treatment alone. The combination of BJJP+BMSCs treatment on CSCs could further enhance the suppressive effect on CSCs. Down-regulation of miR-140 in CSCs partially blocked the effects of BMSCs or BMSCs+BJJP on the expressions of Wnt3a and -catenin as well as the cell viability and apoptosis of CSCs. Reversed expression pattern was found in CSCs transfected with miR-140 overexpression.

CONCLUSIONS

Taken together, we demonstrate that BJJP+BMSCs together could further enhance the suppressive effect on CSCs through regulating miR-140 and suppressing Wnt/-catenin signal pathway. This study demonstrated the potential of BJJP+BMSCs in therapeutic treatment of HCC.

摘要

背景与目的

具有致瘤潜能的癌症干细胞(CSCs)被认为是肝细胞癌(HCC)复发及治疗耐药的关键因素。有文献记载,骨髓间充质干细胞(BMSCs)在保护肝细胞方面发挥重要作用。鳖甲煎丸(BJJP)作为一种中药,已被用于治疗肝纤维化和肝癌。本研究旨在探讨BJJP与BMSCs联合应用于肝癌细胞系的潜在作用。

方法与结果

采用流式细胞术,通过检测CD24、CD133、CD44、CD73、CD105、CD166、CD29、CD14和CD34来鉴定从BALB/c小鼠分离的BMSCs以及从Huh7细胞富集的CSCs。同时也测定了BMSCs的分化潜能。采用CCK-8法和克隆形成试验测定CSCs的细胞活力和增殖能力。通过PCR和蛋白质印迹法测定CSCs生物标志物及Wnt/β-连环蛋白信号通路相关蛋白的表达。应用TOP-Flash/FOP-Flash荧光素酶试验检测β-连环蛋白/TCF的活性。与未处理的CSCs相比,单独用BJJP或BMSCs处理CSCs可导致miR-140表达增加和细胞凋亡,以及CD24、CD133、EpCAM表达降低和细胞活力下降。单独用BJJP或BMSCs处理可使Wnt/β-连环蛋白信号通路相关蛋白Wnt3a和β-连环蛋白的表达下调。BJJP+BMSCs联合处理CSCs可进一步增强对CSCs的抑制作用。CSCs中miR-140的下调部分阻断了BMSCs或BMSCs+BJJP对Wnt3a和β-连环蛋白表达以及CSCs细胞活力和凋亡的影响。在转染miR-140过表达的CSCs中发现了相反的表达模式。

结论

综上所述,我们证明BJJP+BMSCs可通过调节miR-140和抑制Wnt/β-连环蛋白信号通路进一步增强对CSCs的抑制作用。本研究证明了BJJP+BMSCs在肝癌治疗中的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef94/8429943/45863de5c4b8/ijsc-14-3-275-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef94/8429943/8688c3038fc0/ijsc-14-3-275-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef94/8429943/efe7a4f64702/ijsc-14-3-275-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef94/8429943/6551e32a3c1c/ijsc-14-3-275-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef94/8429943/642e24889c18/ijsc-14-3-275-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef94/8429943/45863de5c4b8/ijsc-14-3-275-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef94/8429943/8688c3038fc0/ijsc-14-3-275-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef94/8429943/efe7a4f64702/ijsc-14-3-275-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef94/8429943/6551e32a3c1c/ijsc-14-3-275-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef94/8429943/642e24889c18/ijsc-14-3-275-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef94/8429943/45863de5c4b8/ijsc-14-3-275-f5.jpg

相似文献

1
Bie Jia Jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells.鳖甲煎丸联合骨髓间充质干细胞调节 microRNA-140 以抑制肝癌干细胞
Int J Stem Cells. 2021 Aug 30;14(3):275-285. doi: 10.15283/ijsc20157.
2
Bie Jia Jian pill enhances the amelioration of bone mesenchymal stem cells on hepatocellular carcinoma progression.鳖甲煎丸增强骨髓间充质干细胞对肝癌进展的改善作用。
J Nat Med. 2022 Jan;76(1):49-58. doi: 10.1007/s11418-021-01548-4. Epub 2021 Jul 23.
3
Bie Jia Jian pill ameliorates BDL-induced cholestatic hepatic fibrosis in rats by regulating intestinal microbial composition and TMAO-mediated PI3K/AKT signaling pathway.鳖甲煎丸通过调节肠道微生物组成和TMAO介导的PI3K/AKT信号通路改善胆管结扎诱导的大鼠胆汁淤积性肝纤维化。
J Ethnopharmacol. 2025 Jan 30;337(Pt 2):118910. doi: 10.1016/j.jep.2024.118910. Epub 2024 Oct 5.
4
A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.一种新型小分子WNT抑制剂IC-2具有抑制肝癌干细胞的潜力。
Anticancer Res. 2017 Jul;37(7):3569-3579. doi: 10.21873/anticanres.11727.
5
Irradiated mesenchymal stem cells support stemness maintenance of hepatocellular carcinoma stem cells through Wnt/β-catenin signaling pathway.经照射的间充质干细胞通过Wnt/β-连环蛋白信号通路支持肝癌干细胞干性的维持。
Cell Biosci. 2020 Aug 3;10:93. doi: 10.1186/s13578-020-00449-5. eCollection 2020.
6
MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.微小RNA-1通过抑制Wnt/β-连环蛋白信号通路下调乳腺癌干细胞的增殖和迁移。
Oncotarget. 2015 Dec 8;6(39):41638-49. doi: 10.18632/oncotarget.5873.
7
miR-19 targeting of GSK3β mediates sulforaphane suppression of lung cancer stem cells.miR-19靶向GSK3β介导萝卜硫素对肺癌干细胞的抑制作用。
J Nutr Biochem. 2017 Jun;44:80-91. doi: 10.1016/j.jnutbio.2017.02.020. Epub 2017 Apr 5.
8
Long non-coding RNA HULC promotes proliferation and osteogenic differentiation of bone mesenchymal stem cells via down-regulation of miR-195.长链非编码 RNA HULC 通过下调 miR-195 促进骨髓间充质干细胞的增殖和成骨分化。
Eur Rev Med Pharmacol Sci. 2018 May;22(10):2954-2965. doi: 10.26355/eurrev_201805_15050.
9
microRNA-497 inhibition mitigates myocardial infarction via enhancing wingless/integrated signal pathway in bone marrow mesenchymal stem cells.microRNA-497 抑制通过增强骨髓间充质干细胞中的 Wnt/整合素信号通路减轻心肌梗死。
J Cell Biochem. 2019 Aug;120(8):13403-13412. doi: 10.1002/jcb.28615. Epub 2019 Mar 30.
10
Targeting the Epigenetic Non-Coding RNA MALAT1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma.靶向表观遗传非编码 RNA MALAT1/Wnt 信号轴抑制肝癌干细胞特性和转移的治疗策略。
Cells. 2020 Apr 20;9(4):1020. doi: 10.3390/cells9041020.

引用本文的文献

1
Ferulic Acid Combined With Bone Marrow Mesenchymal Stem Cells Attenuates the Activation of Hepatic Stellate Cells and Alleviates Liver Fibrosis.阿魏酸联合骨髓间充质干细胞可减轻肝星状细胞的活化并缓解肝纤维化。
Front Pharmacol. 2022 May 19;13:863797. doi: 10.3389/fphar.2022.863797. eCollection 2022.
2
Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma.鼓励针对肝细胞癌的基于特定生物标志物的治疗策略。
World J Clin Cases. 2022 Apr 16;10(11):3321-3333. doi: 10.12998/wjcc.v10.i11.3321.

本文引用的文献

1
MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.微小 RNA-140 通过靶向 ZEB2 调控 Wnt/β-连环蛋白通路抑制食管癌进展。
J Surg Res. 2021 Jan;257:267-277. doi: 10.1016/j.jss.2020.07.074. Epub 2020 Aug 27.
2
Irradiated mesenchymal stem cells support stemness maintenance of hepatocellular carcinoma stem cells through Wnt/β-catenin signaling pathway.经照射的间充质干细胞通过Wnt/β-连环蛋白信号通路支持肝癌干细胞干性的维持。
Cell Biosci. 2020 Aug 3;10:93. doi: 10.1186/s13578-020-00449-5. eCollection 2020.
3
miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1.
miR-4458 通过靶向 TGFBR1 抑制 TGF-β 信号通路抑制肝癌细胞的上皮-间充质转化。
Acta Biochim Biophys Sin (Shanghai). 2020 May 26;52(5):554-562. doi: 10.1093/abbs/gmaa029.
4
STYXL1 promotes malignant progression of hepatocellular carcinoma via downregulating CELF2 through the PI3K/Akt pathway.STYXL1 通过 PI3K/Akt 通路下调 CELF2 促进肝癌的恶性进展。
Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):2977-2985. doi: 10.26355/eurrev_202003_20662.
5
EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.EpCAM 高表达肝癌干细胞通过上调 CEACAM1 抵抗自然杀伤细胞介导的细胞毒性。
J Immunother Cancer. 2020 Mar;8(1). doi: 10.1136/jitc-2019-000301.
6
Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy.癌症干细胞:肝癌靶向治疗的潜在突破
Front Pharmacol. 2020 Mar 6;11:198. doi: 10.3389/fphar.2020.00198. eCollection 2020.
7
LncRNA FLJ33360 accelerates the metastasis in hepatocellular carcinoma by targeting miRNA-140/MMP9 axis.长链非编码RNA FLJ33360通过靶向miRNA-140/MMP9轴促进肝细胞癌转移。
Am J Transl Res. 2020 Feb 15;12(2):583-591. eCollection 2020.
8
ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.ZHX2 通过 KDM2A 介导的 H3K36 去甲基化抑制肝癌干细胞样特性。
EBioMedicine. 2020 Mar;53:102676. doi: 10.1016/j.ebiom.2020.102676. Epub 2020 Feb 27.
9
Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.一组癌症干细胞标志物的过表达增强了早期胆管癌进展和复发的预测能力。
J Transl Med. 2020 Feb 10;18(1):64. doi: 10.1186/s12967-020-02243-w.
10
Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment.用嵌合抗原受体 T 细胞膜包覆仿生纳米颗粒为肝癌光热治疗提供了高度特异性。
Theranostics. 2020 Jan 1;10(3):1281-1295. doi: 10.7150/thno.40291. eCollection 2020.